Fragment library design: efficiently hunting drugs in chemical space.
By Susan M. Boyd, G. D. Kloe. 2010
34 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Molecular Biology, Computational Chemistry & Drug Discovery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Jean-Louis Reymond
- Ruud Van Deursen
- Lorenz C. Blum
- C. K. Surratt
- Jeffry D. Madura
- Michael J. Wasko
- Kendy A. Pellegrene
- Lars Ruddigkeit
In Molecular Biology
- Jean-Louis Reymond
- Ruud Van Deursen
- Lorenz C. Blum
- C. K. Surratt
- Jeffry D. Madura
- Michael J. Wasko
- Kendy A. Pellegrene
- Lars Ruddigkeit
In Computational Chemistry & Drug Discovery
- Ruud Van Deursen
- Lorenz C. Blum
- Jean-Louis Reymond
- C. K. Surratt
- Jeffry D. Madura
- Michael J. Wasko
- Kendy A. Pellegrene
- Alán Aspuru-Guzik
Citations in the corpus
- A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets (2015, methodology): “Fragments are drawn from three sources: known biologically active drugs, natural products, and compounds with novel scaffolds (20).”
- Visualisation and subsets of the chemical universe database GDB-13 for virtual screening (2011, background): “The discovery of innovative chemotypes is one of the key chemical problems in small molecule drug discovery, in particular at the level of fragments, a size range which also includes many drugs [1–8].”